These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26559479)

  • 21. A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.
    Schlesinger E; Johengen D; Luecke E; Rothrock G; McGowan I; van der Straten A; Desai T
    Pharm Res; 2016 Jul; 33(7):1649-56. PubMed ID: 26975357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia.
    Yu X; Takayama T; Goel SA; Shi X; Zhou Y; Kent KC; Murphy WL; Guo LW
    J Control Release; 2014 Oct; 191():47-53. PubMed ID: 24852098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
    Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
    Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.
    Kunou N; Ogura Y; Honda Y; Hyon SH; Ikada Y
    J Biomed Mater Res; 2000 Sep; 51(4):635-41. PubMed ID: 10880111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis).
    Nguyen QD; Sadiq MA; Soliman MK; Agarwal A; Do DV; Sepah YJ
    Trans Am Ophthalmol Soc; 2016 Aug; 114():T3. PubMed ID: 27630374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W; Gao H; Xie L; Wang S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations.
    Rahimy MH; Peyman GA; Chin SY; Golshani R; Aras C; Borhani H; Thompson H
    J Drug Target; 1994; 2(4):289-98. PubMed ID: 7858954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; Meyer LC; Du Toit LC; Naylor S; Wanblad C
    J Pharm Sci; 2011 May; 100(5):1819-32. PubMed ID: 21374617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
    Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A poly(ε-caprolactone) device for sustained release of an anti-glaucoma drug.
    Natu MV; Gaspar MN; Ribeiro CA; Correia IJ; Silva D; de Sousa HC; Gil MH
    Biomed Mater; 2011 Apr; 6(2):025003. PubMed ID: 21293056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable drug-eluting stents: promises and pitfalls.
    Di Mario C; Ferrante G
    Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665
    [No Abstract]   [Full Text] [Related]  

  • 33. Biodegradable Cable-Tie Rapamycin-eluting Stents.
    Lee CH; Hsieh MJ; Chang SH; Chiang CL; Fan CL; Liu SJ; Chen WJ; Wang CJ; Hsu MY; Hung KC; Chou CC; Chang PC
    Sci Rep; 2017 Mar; 7(1):111. PubMed ID: 28273914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
    Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N;
    Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery.
    Yan ZC; Bai YJ; Tian Z; Hu HY; You XH; Lin JX; Liu SR; Zhuo YH; Luo RJ
    Mol Vis; 2011; 17():2495-506. PubMed ID: 21976960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly-epsilon-caprolactone intravitreous devices: an in vivo study.
    Silva-Cunha A; Fialho SL; Naud MC; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2312-8. PubMed ID: 19117927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
    Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
    Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of 5-Fluorouracil-Polycaprolactone Sustained-Release Film in Ahmed Glaucoma Valve Implantation Inhibits Postoperative Bleb Scarring in Rabbit Eyes.
    Bi XZ; Pan WH; Yu XP; Song ZM; Ren ZJ; Sun M; Li CH; Nan KH
    PLoS One; 2015; 10(11):e0141467. PubMed ID: 26579716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.
    Stewart SA; Domínguez-Robles J; McIlorum VJ; Gonzalez Z; Utomo E; Mancuso E; Lamprou DA; Donnelly RF; Larrañeta E
    Mol Pharm; 2020 Sep; 17(9):3487-3500. PubMed ID: 32672976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.
    Dou Y; Guo J; Chen Y; Han S; Xu X; Shi Q; Jia Y; Liu Y; Deng Y; Wang R; Li X; Zhang J
    J Control Release; 2016 Aug; 235():48-62. PubMed ID: 27235978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.